Torrent Pharmaceuticals Reports 3% Profit Increase and 55% Revenue Growth in Q1 FY27
Torrent Pharmaceuticals reported a 3 percent rise in net profit to Rs 566 crore for Q1 FY27, with revenue increasing by approximately 55 percent to around Rs 4,920 crore compared to the previous year. Growth was driven by strong performance in India, the US, Brazil, and Germany, despite some supply disruptions in Germany. The company also faced exceptional expenses related to the acquisition and restructuring of J.B. Chemicals. Ameera Shah's term as Independent Director will end on August 1, 2026.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (60/100). Lens Score 33/100.
Outlets measured: businessstandard, freepressjournal. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
freepressjournal broke this story on 30 Jul, 12:07 pm. Other outlets followed.